🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 Join us for the EORTC Older Adult Council #webinar on competing risks in frail patients, in collaboration with the EORTC HNCG and GUCG. 📅19 June 2025 ⏰17:00 – 18:15 CEST 📍Virtual event 🔗 Register now: eortc.org/event/competin… #CancerResearch #ClinicalTrials #Oncology

🚨 We're hiring an Administrative Medical Liaison Officer to support the coordination of our scientific activities! This key role involves working closely with our Medical Representative to ensure seamless operations. Apply now: eortc.org/job/medical-li… #Jobs #Vacancy #Oncology

It has been a pleasure to collaborate with ESOI on the 2025 ESOI-EORTC Workshop taking place in Brussels last week. 👏Congratulations to all the participants and a big thank-you to the faculty, the organising committee, and the sponsors for their invaluable contributions.

🏃‍♀️🏃‍♂️ Congratulations to the EORTC runners who completed the 20 Km of Brussels yesterday! Your dedication, team spirit, and endurance reflect the same energy we bring to our mission every day. Well done! 👏 #CancerResearch #ClinicalTrials #Oncology #20kmdeBruxelles

📢 Pleased to announce a new EORTC publication! The SPECTA-AYA project on adolescents and young adults with high-risk central nervous system tumours, uncovered key theranostic insights for this underserved population. 📚doi.org/10.1016/j.ejca… Cencora #SPECTAplatform

📢 Late Rate Deadline Tomorrow #STATS2025 to learn how to design clinical studies, work in multidisciplinary teams, and evaluate research quality 📅 Date: 10-13 June 2025 👉 Apply now:eortc.org/event/stats202… #CancerResearch #ClinicalTrials #StatisticalMethods #ClinicalResearch

🎉Excited to join #ASCO25 in Chicago! EORTC will present 8 abstracts, 3 oral sessions and 5 posters, sharing breakthroughs in brain, breast, lung, head & neck, melanoma, and genitourinary cancers. Find out more: eortc.org/blog/2025/05/2… ASCO #Oncology #ClinicalTrials

🎉We’re proud to share that the RP-2011 #ReCare cohort of the #E2RADIatE platform reached a major milestone: its 500th patient enrolled since launching in May 2023. This marks the successful completion of the first phase of recruitment. Learn more: project.eortc.org/e2-radiate/202…

🧠Don’t miss Prof Martin Van Den Bent’s oral presentation today at #ASCO25! He’ll share the final results from the CATNON trial on anaplastic glioma, a rare and agressive type of #BrainTumour. 🔗 eortc.org/blog/2025/05/2… ASCO #CancerResearch #ClinicalTrials #Oncology

📢Delighted to share a new publication in Annals of Oncology. PEACE III is the first major Phase III trial to combine an ARPI with radiopharmaceutical that showed statistical significance in meeting the primary endpoint bit.ly/PeaceIII

🩺 Join Professor Nicolas Girard today at 17:36 CDT at #ASCO25! He’ll present the EORTC-1525 NivoThym trial on advanced or relapsed type B3 thymoma or thymic carcinoma. 🔗eortc.org/blog/2025/05/2… ASCO #CancerResearch #ClinicalTrials #Oncology

We’re pleased to announce that Jordan has officially joined the #OligoRARE study with the activation of مؤسسة ومركز الحسين للسرطان. This marks the first trial initiated under the EORTC Middle East Coordination Office (MECO) agreement.🌍 Anticancer Fund Piet Ost Matthias Guckenberger

In PEACE-3 (EORTC 1333), the addition of 6 cycles of Ra223 to enzalutamide improves PSA response time and rates (≥90%), ALP reduction time (≥30%), and ALP normalization at 6 and 12 months. EORTC silke gillessen Andrey Soares GETUG CancerTrialsIreland 🌈 SOGUG

At #ASCO25 , Michail ignatiadis presented the study design of TREAT ctDNA, an academic randomized trial investigating ctDNA dynamics and the novel oral SERD elacestrant in HR+/HER2- early breast cancer clinicaltrials.gov/study/NCT05512… Institut Jules Bordet Instituut EORTC

🌍Join us at #ASCO25! Today at 9:57 AM CDT, Dr Alexander van Akkooi will present the primary analysis of the EORTC-2139 Columbus-AD trial, focusing on high-risk stage II #melanoma. Don’t miss this! 🔗eortc.org/blog/2025/05/2… ASCO #CancerResearch #ClinicalTrials #Oncology

PROMISING RESULTS FOR STAGE IIB/C PRESENTED AT ASCO. MIA surgeon, Assoc Prof Alex van Akkooi, has delivered an oral abstract at #ASCO25 on early results from the COLUMBUS-AD trial. The trial, which was run through the European Organisation for Research and Treatment of Cancer

What an incredible experience to take part in this year’s ASCO Congress! Congratulations to all the EORTC members who represented us at this prestigious event.👨‍⚕️ Learn more about the EORTC abstracts presented at #ASCO25: eortc.org/blog/2025/06/0… ASCO #CancerResearch #Oncology

📢 Just released: the EORTC 2024 Annual Report is now online! From groundbreaking clinical trials to expanded global partnerships, see how we are driving progress in cancer treatment, together. 🔗 eortc.org/blog/2025/06/0… #Oncology #CancerResearch #ClinicalTrials

We are delighted to announce the official start of the Horizon Europe 🇪🇺 funded DE-ESCALATE Project #ClinicalTrial on metastatic #prostatecancer, in collaboration with Syreon Research Institute. More: eortc.org/blog/2025/06/0… European Commission #DEESCALATE_Horizon #HorizonEurope #MensHealthWeek